✦ LIBER ✦

Anti-HCV antibody titers before and after interferon therapy in 43 patients with chronic non A non B hepatitis: Relationship with response to treatment

✍ Scribed by Luncl, F.; Perrin, M.; Valla, D.; Cadranel, J.F.; echabrolle, A.Devil; Grippon, P.; Huraux, J.M.; Opolon, P.

Book ID: 121914110
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 118 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)91501-M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between anti-HCV antibodies

Relationship between anti-HCV antibodies measured by a quantitative riba assay and response to interferon in patients with chronic non A non B hepatitis

✍ Lunel, F.; Maisoneuve, P.; Marcellin, P.; Boyer, N.; Valla, D.; Opolon, P.; Benh 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Serum HCV-RNA, transaminases and HCV-ant

Serum HCV-RNA, transaminases and HCV-antibodies in patients with chronic non-A, non-B hepatitis treated with interferon alpha-2B (IF)

✍ Willems, M.; Nevens, F.; Moshage, H.; Fevery, J.; Yap, S.H. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Hepatitis C viraemia rebound after “succ

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non-A, non-B hepatitis

✍ Dr. J. A. Garson; S. Brillanti; C. Ring; P. Perini; M. Miglioli; L. Barbara 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w

Clinical predictors of response to recom

Clinical predictors of response to recombinant interferon-α treatment in patients with chronic non-A, non-B hepatitis (hepatitis C)

✍ G. L. Davis; K. Lindsay; J. Albrecht; H. C. Bodenheimer Jr; L. A. Balart; R. P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

Significance of antibody to hepatitis C

Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: Relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis

✍ Eiji Tanaka; Dr. Kendo Kiyosawa; Takeshi Sodeyama; Yoshiyuki Nakano; Kaname Yosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

In a retrospective study, antibody to hepatitis C virus (anti-HCV antibody) was measured in 80 patients with acute viral hepatitis (type A, 18; type B, 21; type non-A,non-B, 41). Anti-HCV antibody was found in 12 of 20 patients (60%) with non-A,non-B post-transfusion hepatitis (NANB-PTH) and in 9 of

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of